RESEARCH-USE BIOSIMILAR ANTIBODY
Avizakimab
Monoclonal antibody · IgG1
Avizakimab (BOS161721) is a humanized IgG1 monoclonal antibody that targets interleukin-21.
TARGETIL21
YMonoclonal antibody
CATALOGSC-BS-750
CATALOG NUMBERSC-BS-750
MOLECULAR WEIGHTApprox. 145.2 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Avizakimab (BOS161721) is a humanized IgG1 monoclonal antibody that targets interleukin-21.
Avizakimab is a recombinant research-use antibody directed against IL21.